One of the basic theories oftwentieth-century scientific medicine is the receptor concept. It deals with the question of how information can be submitted to the cell. Receptors can be described as "small, discrete area(s) on the cell membrane or within the cell with which molecules or molecular complexes (for example, hormones, drugs, and other chemical messengers) interact" .1 The receptor concept became increasingly important, especially for pharmacology, as it explained the binding of drugs to cells and drug-effects on specific tissues and organs.
Paul Ehrlich and his Receptor Concept
This paper focuses on Paul Ehrlich and the development of his receptor concept between 1878 and approximately 1905, when the concept was brought to a certain conclusion. The purpose is to deal with a basic problem: as there are two independent approaches to the subject, one could assume that receptors are "objective" facts of nature and that the "discovery" of the receptors was somehow "inevitable". This impression contrasts with the sociological constructivist interpretation of science: discoveries do not neatly correspond to objective entities in nature. They are dependent on the cultural setting, for example, the social position of the researcher and the local scientific system.3 This paper will show that the constructivist view can be helpful in understanding Ehrlich's "discovery" of the receptor concept as the latter emerged from the dual effect of social and scientific aspects of his biography. This means that although the roots of Ehrlich's ideas can be traced back to early stages ofhis career, although his ideas appeared in a logical order and although he was driven by a leitmotifthroughout his academic life, it was far from clear why and how he would develop the receptor concept. My analysis provides some insights into the history of modem medical science and contributes to our understanding of the receptor concept's position in early twentieth-century medicine. In this context it is not my purpose to follow up the history of the usage of Ehrlich's concept in pharmacology. By contrast, I envisage this paper as a contribution to the analysis of the difficult starting position of the receptor idea. Its birth and its character contain the roots of problems, which caused many difficulties in the successful introduction of the idea to pharmacology after 1945.
I will first discuss Ehrlich's basic scientific ideas and the traditional views on his academic life. Then I will go into more detail and take a close look at Ehrlich's career in relation to his work on receptors. Finally, I will summarize and evaluate my findings.4
The Roots of Ehrlich's Research and the Inevitable Discovery of the Receptors In any focused analysis of Ehrlich's ideas, the introduction of his receptor concept appears to be consistently planned and realized. As a medical student at the universities of Strasbourg and Breslau he concentrated on the staining of histological specimens. Breslau became especially important: he was influenced above all by the pathologist Julius Cohnheim (1839-1884), one of the few German pathologists to use animal experimentation in addition to pathological anatomy.5 Cohnheim's research into pathological function, in Cay-Riidiger Priill contrast to pathological morphology, was accompanied by close contacts with clinicians. He also influenced many British medical students and contributed in this way to the introduction of "clinical pathology" into Britain.6 Under his influence, Ehrlich followed the path of applying laboratory findings to clinical practice and, in fact, became a pioneer of clinical pathology in Germany.
Ehrlich's basic scientific ideas can be briefly summarized: first, he made a claim for the routine application of the method of staining to medicine in general and to histology in particular. Second, he supported the theory that the staining process relied on a chemical reaction between dye-stuff and cell.7 These two ideas formed the basis or leitmotif of Ehrlich's side-chain and then receptor theory. As early as 1878 Ehrlich had written in his dissertation of "a definite chemical character of the cell"8 which was necessary for its reaction with a dye. In 1897, almost nineteen years later, when he worked on immunological problems, Ehrlich returned to this point and developed his chemical "side-chain theory". Certain "side-chains" of the cell were able to bind certain toxins. Because these occupied side-chains would then become unable to fulfil their physiological functions, the cell would overcompensate by producing a lot of additional side-chains, which would be released into the blood-stream, where they acted as antibodies or antitoxins.9 Against this background, in 1900, Ehrlich introduced the term "receptor" as a designation of the side-chain's function.10 In 1908, Ehrlich was awarded the Nobel Prize for his work in immunology.
A shift in thinking enabled Ehrlich to apply his concept to drug binding. He first thought receptors would bind toxines and nutritive substances only. Many drugs could be extracted from tissues easily and so they seemingly could not be bound firmly to the cell. Therefore they could not evoke the production of side-chains." Ehrlich's theory allowed-as a future perspective-drug binding to cells only indirectly, as he proposed that certain chemical bodies or groups (Korperklassen) with specific binding capacities to specific organs could be used as "vehicles" (Lastwagen) to carry artificial substances to the site of effect.12 Not before 1907-with reference to his own work on the effect of dyes on trypanosomes and 6Cay-Rudiger Priill, Medizin am Toten oder am Lebenden? Pathologie in Berlin undin London 1900 bis 1945 , Freiburg, 1999 esp. pp. 389-92 ; Russell C Maulitz, 'Rudolf Virchow, Julius Cohnheim, and the program of pathology ', Bull. Hist. Med., 1978, 52: 162-82. 7Conceming Ehrlich and Ehrlich' s Seitenkettentheorie und ihre Anwendung auf die kunstlichen Immunisierungsprozesse, Jena, Fischer, 1902, esp. pp. 1-25 . See also Bruno Heymann, 'Zur Geschichte der Seitenkettentheorie Paul Ehrlichs', Klin. Wochenschr., 1928, 7: 1257-60; Arthur M Silverstein, A history of immunology, San Diego and New York, Academic Press, 1989, esp. pp.64-6,94-9. l°Paul Ehrlich and Julius Morgenroth, 'Ober Haemolysine. Dritte Mittheilung' (Berliner Klinische Wochenschrift, 1900) , in Himmelweit (ed.) Langley's notion of "receptive substances"-did Ehrlich accept the binding of drugs to receptors. 13 For this purpose there would be specific "chemoreceptors". The drug needed to have a greater affinity to the chemoreceptors of the invading organisms, for example the trypanosomes, than to the chemoreceptors of the host's body. The concept of "specific affinity" was applied to the pharmacological realm. Based on early nineteenth-century investigations of the relationship between chemical composition and physiological action ofcertain drugs,14 Ehrlich was now able to explain all the phenomena in connection with the effect of a chemotherapeutic drug, for example drug resistance, with the help of the receptor concept. The receptors became the theoretical basis for his subsequent work with the dye "trypan red" and with the arsenic compound "atoxyl" to combat trypanosome infections, ending with the discovery of Salvarsan, the first chemotherapeutic substance for the treatment of syphilis, in 1910. Ehrlich's profile of daily work enables us to estimate the impact of the receptor concept on his research at these times. The "side-chain" theory was the outcome of one specific study-his habilitation thesis (teaching licence) of 1885, which was dedicated to Frerichs. On the basis of countless animal experiments, Ehrlich wanted to estimate the "oxygen-need of the organism" (Sauerstoff-Bediirfniss des Organismus). The dyes served him to indicate the different degrees of oxygen affinity of the various organs. Following the infusion of dyes, the animals were killed after certain intervals of time, and dissected. The colouring of the tissues indicated the metabolic activities of the single organs and tissues and enabled a certain classification. Ehrlich concluded that the inner part of the cell (protoplasm/ Protoplasma) was able to utilize oxygen. According to Ehrlich, the protoplasm had side-chains, which could bind oxygen. This complex could be burned in the protoplasm and transformed into energy. His study presented a theoretical basis for his staining methods, but the side-chain as predecessor of the receptor played no important role in his discussion of oxygen utilization. Moreover, Ehrlich focused on the organs, the character of the protoplasm and of the surrounding paraplasm (Paraplasma, more unspecific areas of the cell, die mehr indifferenten Territorien des Zellenleibes) of the cell.36 The side-chains are mentioned in Ehrlich's 69-page habilitation thesis (in Himmelweit's edition of the collected works) only six times and then never again during the period of his work under Frerichs.37
Ehrlich's major aim was to achieve clinically applicable results. He could influence the work on the wards when connecting different fields: staining methods, animal experimentation, clinical work and human therapeutic experiments. This filled Ehrlich's entire working time. Remarkably, he achieved his aims without any deeper insights into the exact way in which substances bind to cells. This explains why there was no discussion ofthe side-chains in the years after the publication of his habilitation thesis. In 1891 Ehrlich was still calling himself a "clinician",38 and he had acquired his teaching licence in the field of "practical continued to be the spiritus rector of the whole project, and he urged his assistants to perform more and more animal experiments to consolidate his theory. Ehrlich's laboratory notes show this, as for instance when he demanded: "Please also show me the Pyrodinanimals", or simply "Where is the ape?"70 Accordingly, the "side-chain theory" developed. The "toxoids", those poisons capable of cell-binding, were supplemented by the "toxons" (Toxone) only a year later, in 1898.71 The toxons were also ineffective poisons, but, in contrast to the toxoids, they were synthesized and released by the microbe itself and had not lost their toxophore group.
Besides analysing poisons, Ehrlich concentrated on the mechanisms and processes of the side-chain theory itself. The animal experiments on haemolysis, i.e. the solvent action of antibodies on red blood corpuscles, seemed to be helpful. This could be compared with antibodies attacking bacilli. Some studies on haemolysis, published together with Morgenroth, enabled Ehrlich to improve the side-chain theory decisively. The so-called "addiment" (Addiment), was responsible for the dissolution of the red blood cells through binding to an antibody or "immune-body" (Immunkorper), enabling this antibody to bind to red blood cells and to dissolve them. Consequently, Ehrlich assumed that there were not only antibodies with one binding group but also antibodies with two binding groups. These were able to bind the "addiment" as well as the red blood cell. Now Ehrlich compared haemolysis with the physiological process of nutrition. This increased the impact of his theory. The addiment could be compared with a digestive ferment. A double-binding sidechain attached to the surface of a cell could bind both a digestive ferment and "giant molecules" (Riesenmolekiile), i.e. unprepared nutritive substances. These giant molecules could be prepared for cellular digestion by the digestive ferment.72 In this way, Ehrlich opened up the path from the more or less narrow immunological terrain to the understanding of the general metabolism of the human organism.
The side-chain theory appeared to be a good explanatory model to uncover the deepest secrets of biological chemistry. In 1899, Ehrlich postulated a countless number of sidechains, which would adapt to the "constantly changing chemistry" of the body. This chemistry would be influenced by race, sex, nutrition, energy, secretion and other factors, and so there was a continuous change taking place in the blood serum. Furthermore, not only in the case of haemolysis but also in regular conditions, the blood contained immune bodies 68Goldsmith, op. cit., note 5 above, p. 78. Paul Ehrlich and his Receptor Concept theory had "passed the test perfectly".92 The appearance of scientific phenomena that were inconsistent with his theory were explained by Ehrlich as a result of the highly intricate conditions of the animal organism. The inconsistencies would serve to deepen the theory and to promote its success.93 Thus a theory should not be dismissed as soon as any contradiction occurred, but should be carefully rethought. Ehrlich saw himself as a pioneer of a new medicine of the future, and he compared his "side-chain theory" with Rudolf Virchow's (1821-1902) "cellular pathology", which also had not been successful at once.94
The insecure basis of Ehrlich's theory provoked critics even at an early stage in its development. The critics and his way of dealing with them led Ehrlich deeper into his receptor concept. He attributed what he called the "unitarian view" (unitarischer Standpunkt) to many of his critics. This attitude stood in sharp contrast to his own "pluralistic conception" (plurimistische Anschauung). Based on their own experiments, the unitarians attacked specific points of the side-chain theory and thereby questioned Ehrlich's microcosmos of immunological substances.95 Ehrlich identified one opposing group of scientists at the Pasteur Institute in Paris: the French immunologist and bacteriologist Emile Roux , made deputy director in 1895 and since 1904 director of the Pasteur Institute, his Belgian colleague and co-worker Jules Bordet , and the Russian immunologist and bacteriologist Elie Metchnikoff (1845 Metchnikoff ( -1916 , who had worked at the Institute since 1888. The dispute between these three researchers on one side and Ehrlich on the other began about 1897, and went on for about ten years.96 The most important conflict was, however, with Jules Bordet. The latter had developed a special theory on the dissolution ofred blood cells. In 1900, Bordet declared there to be no direct relation between immune bodies and complement. The red blood cells were merely made sensitive by the immune bodies-a view rejected by Ehrlich as purely mechanistic. Following that, the cells were influenced by the complement, which Bordet named "alexine" (Alexin). Furthermore, Bordet questioned the existence of a variety of immune bodies on the basis of his own experiments on haemolysis. In one species there was only one alexine, causing both haemolysis and bacteriolysis.97
Such attacks annoyed Ehrlich considerably, and the example of the Paris trio reveals his methods of dealing with critics of the side-chain theory. Ehrlich : "I was most delighted to recognize you as one of the warmest friends of the theory, but even more that you could achieve such new and fundamental insights with its help". In contrast, he wrote to a pharmacologist in Halle, Germany, "that every impartial person reading the literature has to count you as an absolute opponent".'01 Again, Ehrlich related the remark to "the theory", which occupied him more and more in the years after 1897. This becomes apparent through other critics of his concept.
Ehrlich's style of dealing with critics of the side-chain theory can also be found in his controversy with the physical chemist Svante Arrhenius (1859 Arrhenius ( -1927 and his student Thorvald Madsen (1870 -1957 Gruber (1853 Gruber ( -1927 Gruber.105 Ehrlich rejected the hygienists' criticism entirely as "stupid" (blodsinnig) and treated it as a "quantitene'gligeable". This again led Gruber to point out "that he solely reproaches him [Ehrlich] Cambrosio, Daniel Jacobi, and Peter Keating, 'Ehrlich's "beautiful pictures" and the controversial beginnings of immunological imagery ', Isis, 1993, 84: 662-99, esp. pp. 667-9, 684 ' (Berliner Klinische Wochenschrift, 1906) , in Nachlass Althoff A I, GStA PK. VI. HA, Rep. 92, No. 258, p. 66. 123Liebenau comments that the Institute in Frankfurt gave Ehrlich the opportunity to conduct "controlled bedside trials". Besides the problem of using modem terms and methods anachronistically, it should be remembered that Ehrlich was no longer attached to a clinical unit and that he relied on clinical colleagues to perform therapeutic human experimentation. See Liebenau, op. cit., note 46 above, p. 70.
124 ... nachdem ich so lange serumtherapeutische fragen fast ausschliesslich bearbeitet habe, mich wieder etwas mehr meinem alten lieblingsgebiet theorie der histologischen und biologischen farbung zuzuwenden."; "Nach dem langen immunitats zauber komme ich jetzt wieder dazu, mich meinem alten lieblingsgebiet der farbstoffe wieder etwas zuzuwenden .. .". See Paul Ehrlich to the Badische Paul Ehrlich and his Receptor Concept prostitutes and children without information and consent, tested several dyes for Ehrlich and discussed with him the patients chosen.129 Other colleagues were not as helpful as Neisser.
Ehrlich repeatedly requested them to test his substances. Even if the clinician was in principle prepared to undertake the experiments, Ehrlich had to press forcefully for tests to be done and the results reported. The system did not work well and from June 1899 Ehrlich showed signs of frustration. He remarked to a colleague that "all these gentlemen undertake the staining therapy more or less to do me a favour but not out of deep conviction,. 130
Finally, dye testing appears to have been a futile attempt to restore the old Charite conditions, where laboratory work and animal experimentation could be linked with clinical expertise. Ehrlich's favourite style of work was so well-known that in 1899 the administration of the city of Frankfurt feared that the patients of the city hospitals would be "used for experimental purposes".'3' But what was left during his first years in Frankfurt were the merely theoretical studies on the receptors, based on animal trials and test tubes. Although basically satisfied with his independent position and his working conditions,'32 Ehrlich also detailed the drawbacks when he described his work on the receptors in 1901: "Because I myself am not in a position to perform such investigations on a large number of patients, I thought it to be my duty to clarify my point ofview and this way to lay the basis of the work in a field whose importance for pathology and therapy presumably will be fully acknowledged only after many years". ' chairs of pathology on one side and clinical disciplines on the other. Although burdened with problems, Ehrlich made rigorous efforts to initiate the testing of dyes with the help of clinical colleagues even after he started to work in earnest on the side-chain and receptor theory. These efforts were not successful, and in this situation the theoretical evidence of his approach became more important than ever. In his institute, Ehrlich concentrated on constructing a comprehensive theory, not only of immunological processes but also of the human metabolism in general. The final aim continued to be the practical application to man, based on laboratory research. But at first, Ehrlich was contrained to satisfy himself, the scientific community and the public with vague assumptions about the future effectiveness of his concept in modem medicine. The critics of the side-chain and receptor theory, who raised their voices shortly after Ehrlich had developed his ideas, stimulated the further 135Georg Joannovics, 'Paul Ehrlich 
